Poison that Indian Corporates Need: About Time to Bring ‘Poison-Pill’ in India?
[By Shaurya Singh and Sanya Goel] The authors are students at the Jindal Global Law School, Sonipat. The shareholder rights plan, commonly known as the ‘Poison-pill’ is a strategy used to defend against a hostile takeover by issuing new shares at discount to the existing shareholders other than the acquirer. This dilutes the shareholding of the acquirer while providing an opportunity to the other shareholders to raise their holdings at a discounted price. Therefore, the cost of acquisition significantly rises which would make the target company less attractive to the acquirer considering its higher price. Hence, deterring the hostile acquirer to complete the acquisition and pull out of the deal. This defense strategy has proven its mantle by breaking the jaws of some of the biggest corporate sharks over the years in the US. However, a series of regulations make the poison pill illegal in India. This article stresses the need for importing the poison pill to safeguard Indian companies and points out the fault in the current regulations which freely facilitate hostile takeovers. The Paramount of Defence: There have been several instances where this strategy has proved its effectiveness by saving well-known companies from non-consensual takeovers. Yahoo, acquired the poison pill in 2001 to save itself from being acquired by Microsoft. Along the same lines, Netflix, the current largest streaming service used the strategy as a defence against Carl Icahn’s takeover. Hence, the viability of the Poison Pill is very evident but especially when being used as the only defence strategy it might not guarantee complete safety from the takeover. Swallowing the pill: Poison-pill on paper makes up for a very robust strategy, however, there might be some cases where the acquirer has enough resources to complete the deal regardless, especially when the acquisition is happening without keeping profitability at the centre. In such cases, the acquirer would not care if the profitability of the venture is being compromised or not. Hence, the higher cost of acquisition is less likely to create a deterrence making the poison pill useless. For instance, Elon Musk’s bid for Twitter was not motivated by profits but was rather being done to save the freedom of speech of individuals on the internet. According to Musk, Twitter being one of the most influential social media platforms, was not fully allowing individuals to express free speech and he wished to acquire it to allow free expression. He pitched an offer of 43 billion dollars which was more than entire the market capitalisation of Twitter (37 billion USD). Here, Twitter did initially deploy the poison pill to avoid acquisition but the board later did accept the Musk’s Bid considering the value of the offer. The offer was withdrawn later, but the pill would not have saved Twitter given the amount of money Musk was ready to spend on the deal. A key take away from the said case is that if the acquirer has enough resources, is willing to pay the high cost of acquisition, and can directly or indirectly influence the board of the company, then the target company would not be able to defend itself only by relying on the pill. However, the case of Twitter itself is an exceptional scenario as a majority of the hostile takeovers are motivated by profitability. Therefore, a higher cost of acquisition due to the poison pill can save the target company in most cases. Additionally, the presence of a staggered board of directors comprised of firm individuals adds to the effectiveness of the pill. The Staggered Aegis: The provision for a staggered board of directors has been introduced in India through the Companies Act, 2013. While Section 169 of the Companies Act, 2013 allows for the removal of a director from the company before their period in office expires given that they are given a fair chance to be heard, exceptions to the same are provided in Section 242 and Section 163. A director appointed by the NCLT under Section 242 is not subject to the provisions of Section 169. Similarly, the provisions of Section 169 do not apply in a situation where the company has availed the option to appoint two-thirds of the total number of directors in compliance with the principle of proportional representation of Section 163 which basically translates to the existence of a staggered board. The staggered board complements the pill and these two together make a very viable defence. Theoretically, the acquirer could fire the entire current board and exert control over the newly elected board, thereby dismantling the pill. The staggered board prevents that. Therefore even in the presence of multiple resisting shareholders, the acquirer would not gain control over the board for a long time. The introduction of the staggered board is indeed a positive step but to fully utilize its defensive aspect poison pill is needed, which is restricted by a series of regulations framed by SEBI. The Fault in Our Codes Considering the regulations that regulate takeovers, it is safe to claim that India is a takeover-friendly country. This may not necessarily be a negative thing, given that the legislation has also been flexible enough to permit M&A transactions with minimum intrusion. But that does not mean that the law should freely allow hostile takeovers. The SEBI (Substantial Acquisitions of Shares and Takeovers) Regulations, 2011 or the ‘Takeover Code’ mandates the acquirer to make a public announcement once it obtains 25% of the shares and this is the only major obligation for the acquirer to undertake a takeover. On the other hand, 26(c) of the takeover code prohibits poison pills, as it states that the target company can not issue any securities which entitle the holder to voting rights. Also,26(d) refrains the target company to “implement any buy-back of shares or effect any other change to the capital structure”. Additionally paragraph 13.1.2 chapter 13 SEBI (Disclosure and Investor Protection) Guidelines, also restricted a company from deploying the poison pill as it did not allow for discount warrants less than the
Poison that Indian Corporates Need: About Time to Bring ‘Poison-Pill’ in India? Read More »









